What is HealthRhythms?
Established in 2014 and headquartered in New York, HealthRhythms operates at the intersection of behavioral science and digital health. The company specializes in the development of sophisticated sensing platforms designed to monitor and interpret behavioral patterns, providing actionable insights for mental health practitioners and patients alike. By transforming passive data into clinical intelligence, HealthRhythms addresses the critical need for objective metrics in a field traditionally reliant on subjective reporting. Its market position is defined by a commitment to evidence-based innovation, bridging the gap between academic research and scalable enterprise health solutions.
How much funding has HealthRhythms raised?
HealthRhythms has raised a total of $13.3M across 3 funding rounds:
Grant
$2.1M
Debt
$150K
Angel/Seed
$11M
Grant (2017): $2.1M with participation from NIH
Debt (2020): $150K led by PPP
Angel/Seed (2022): $11M supported by Brook Byers and GSR Ventures
Key Investors in HealthRhythms
NIH
The National Institutes of Health is the primary agency of the United States government responsible for biomedical and health-related research, providing foundational support for scientific innovation.
Brook Byers
A prominent venture capitalist and partner known for long-term strategic investments in transformative healthcare and technology companies.
GSR Ventures
A venture capital firm specializing in early-stage investments in technology companies, with a strong focus on digital health and AI-driven platforms.
What's next for HealthRhythms?
With the recent influx of capital, HealthRhythms is well-positioned to accelerate its product roadmap and expand its footprint within the enterprise health ecosystem. The strategic focus will likely shift toward scaling its behavioral sensing infrastructure to meet the demands of large-scale healthcare providers and insurance networks. As the company matures, the integration of its proprietary technology into standard clinical workflows will be paramount. Future growth will depend on the firm's ability to maintain its rigorous research standards while navigating the complexities of regulatory compliance and data privacy in the rapidly evolving digital therapeutics landscape.
See full HealthRhythms company page
